Colchicine is a medication that is being studied for its potential to reduce inflammation in the walls of the coronary vessels. In this trial, researchers are investigating whether colchicine can help prevent or slow down the development of atherosclerosis, which is a condition where the arteries become narrowed and hardened due to a buildup of plaque. This condition can be accelerated by certain cancer treatments known as immune checkpoint inhibitors. By reducing inflammation, colchicine may help protect the heart and blood vessels in patients undergoing these cancer treatments.

Atherosclerosis – Atherosclerosis is a condition where the arteries become narrowed and hardened due to a buildup of plaque on the artery walls. This plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. Over time, the plaque can harden and narrow the arteries, limiting the flow of oxygen-rich blood to organs and other parts of the body. As the disease progresses, it can lead to reduced blood flow, which may cause symptoms like chest pain or leg pain during physical activity. In advanced stages, atherosclerosis can lead to serious complications if the plaque ruptures, potentially causing blood clots. The progression of the disease is gradual and can occur over many years.

Cancer – Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. These cells can invade and destroy normal body tissue, and they have the potential to spread throughout the body. The progression of cancer varies depending on the type and location of the cancer, as well as the individual characteristics of the patient. In general, cancer begins when genetic changes interfere with the normal regulation of cell growth and division. As cancer progresses, it can form tumors, invade nearby tissues, and spread to other parts of the body through the bloodstream or lymphatic system. The rate of progression can vary widely, with some cancers growing slowly and others advancing rapidly.